Tuesday, 31 Mar 2020

You are here

RheumNow Week in Review - 3 June 2016

This week's highlights from RheumNow.com include:

  1. In a study of knee OA patients they examined the frequency of venous thrombotic events (VTE) (n=4020) and compared with controls having VTE(1:5). NSAID use (diclofenac, meloxicam, ibuprofen, coxibs; but not naproxen) was associated with a ~40% increase VTE risk.  https://t.co/itQexYqRk8
  2. Myositis experts consensus says that after steroids, azathioprine, methotrexate and mycophenolate are most commonly chosen agents to manage myositis. https://t.co/wboHZ7dJQe
  3. FDA rules to lower salt content by manufacturers & restaurants – recommending a decrease in daily salt  intake from 3.4 to 2.3 g/day. https://t.co/wJC7G5DNZS 
  4. 1487 patients with low back pain were reviewed for their medication use. Low rates of med use found: only 18.7% taking meds for back pain; anxiolytics 14%; NSAIDs 12%; analgesic 7%; muscle relaxants 3%; opioids 1.6%. https://t.co/oJH6DCWP0D
  5. Recurrent acute anterior uveitis responds to golimumab 50 mg qmo; 12/15 eyes from B27+ AS patients improve, going into remission https://t.co/0ttwTe56zv
  6. Samsung Bioepis has a new biosimilar “Flixabi” (a Remicade biosimilar) approved for all 6 indications in 28 EU states & Norway, Iceland. https://t.co/oHwkbozHSG
  7. Morning Stiffness Madness - Dr. Cush debunks the importance of morning stiffness as an inflammatory indicator. 
  8. Patient Reluctance to Take Bisphosphonates
  9. Lower GI Perforation Risk Noted for Tofacitinib and Tocilizumab
The author has received research/grant financial support on this subject
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

TeleRheumatology - a TED Talk by Alvin Wells, MD

RheumNow Live 2020 featured a series of shorter STEP (TED-like) talks. This one features Dr. Alvin Wells discussing the opportunities and new paradigms encumbent with telemedicine in rheumatology.

RheumNow Podcast – New World Order (3.27.20)

Dr. Jack Cush reviews the news and COVID developments from this past week.

Global Rheumatology Alliance Registry Will Study COVID-19

In the midst of a global pandemic of the 2019 Novel coronavirus acute respiratory disease (COVID-19), a small handful of Rheumatologists gathered on social media to collectively grapple with the impact of this virus on vulnerable populations with rheumatic disease.

RheumNow Podcast- COVID Siege (3.20.20)

Dr. Jack Cush reviews the past week of COVID-19 news and advances.

COVID-19 Rheumatology News

With the COVID-19 pandemic dynamically changing, we have provided several news items germane to the Rheumatologist.